John Christopher Lindon
Directeur/Membre du Conseil chez Metabometrix Ltd.
Profil
John Christopher Lindon is currently a Director at Metabometrix Ltd.
and a Professor at Imperial College London.
Previously, he was a Professor of Biomolecular Medicine at the University of London and Head of Spectroscopy at Wellcome Research Laboratories.
He received his undergraduate degree from the University of Birmingham.
Postes actifs de John Christopher Lindon
| Sociétés | Poste | Début |
|---|---|---|
Metabometrix Ltd.
 Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
| Imperial College London | Corporate Officer/Principal | - |
Anciens postes connus de John Christopher Lindon
| Sociétés | Poste | Fin |
|---|---|---|
| Wellcome Research Laboratories | Corporate Officer/Principal | 01/01/1995 |
| University of London | Corporate Officer/Principal | - |
Formation de John Christopher Lindon
| University of Birmingham | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Metabometrix Ltd.
Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Commercial Services |
| Wellcome Research Laboratories |
